Latest filing published 11 Nov 2024 for Oncimmune Holdings plc, €120k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Martin Gouldstone: trading record in brief
Martin Gouldstone discloses dealings in Oncimmune Holdings plc to RNS (LSE). Between 23 October 2024 and 8 November 2024, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 1 purchase, €12k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 1 option exercise.
The latest filing, published on 11 November 2024, reports an option exercise of €120k in Oncimmune Holdings plc. The most recent open-market purchase was published on 11 November 2024, 727 days ago. Filings reach the RNS (LSE) feed a median of 3 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Martin Gouldstone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 589,971 shares@ £0.169510.5% of flowOutside a trading venueISIN GB00BYQ94H38RNS:5424771-3
- 5,588,661 shares@ £0.1588.4% of flowOutside a trading venueISIN GB00BYQ94H38RNS:5424771-5
- 66,667 shares@ £0.151.1% of flowAIM, London Stock Exchange (XLON)ISIN GB00BYQ94H38RNS:5424771-1Canonical exit: 21 Jan 2025 (T+90)
3 of 3 declarations